文献速递急腹症与外科感染围术期管理与 ERAS

单孔胸腔镜纤维板剥脱术治疗Ⅲ期结核性脓胸158例

[Uniportal thoracoscopic decortication for stage Ⅲ tuberculous empyema of 158 cases].
PubMed 文献 · Zhonghua Wai Ke Za Zhi · 2022-01-01

回顾性分析158例Ⅲ期结核性脓胸患者接受单孔胸腔镜全纤维板剥脱术的资料,其中男性127例、女性31例,年龄32(28)岁。1例中转开胸,无围术期死亡,术后随访149例(94.9%)恢复至Ⅰ级。结论认为该术式联合规范抗结核治疗安全可行、远期恢复良好。

要点

  • 单孔胸腔镜联合部分肋骨切除与自制骨膜剥离器可完成Ⅲ期结核性脓胸全纤维板剥脱。
  • 术后持续漏气(>5天)发生率为80.3%(126/157),无围术期死亡。
  • 随访149例(94.9%)恢复至Ⅰ级,无复发。

核心结论

  • 借助特殊器械,单孔胸腔镜对Ⅲ期结核性脓胸患者行全纤维板剥脱术安全可行,结合术后规范抗结核治疗远期恢复效果良好。

研究设计与样本

  • 回顾性分析2017年8月至2020年7月上海市肺科医院胸外科158例Ⅲ期结核性脓胸患者,男127例、女31例,年龄32(28)岁(范围14~78岁)。

主要发现

  • 早期1例因纤维板过厚无法有效牵拉中转开胸,余按原计划完成手术。
  • 手术时间2.75(2.50)h(范围1.5~7.0 h),术中出血量100(500)ml(范围50~2 000 ml),术后住院时间5.00(2.25)d(范围2~15 d),术后胸腔引流时间21.00(22.50)d(范围3~77 d)。
  • 术后1例因胸腔引流量多行开胸止血,1例发生切口感染,余无重大并发症,无围术期死亡。
  • 持续漏气(>5天)发生率为80.3%(126/157)。
  • 随访20(14)个月(范围12~44个月),所有患者无复发,149例达Ⅰ级恢复、7例Ⅱ级、1例Ⅲ级。

临床怎么用

  • 对Ⅲ期结核性脓胸可行单孔胸腔镜全纤维板剥脱术,术中节段切除特定5 cm长肋骨并借助切口保护套与特殊器械获取操作空间。
  • 术后无漏气且引流液清亮<50 ml/d时复查CT,肺较前复张后拔除胸腔引流管,继续抗结核治疗。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To examine the safety and feasibility of uniportal video-assisted thoracoscopic (VATS) decortication in patients presenting with stage Ⅲ tuberculous empyema. Methods: From August 2017 to July 2020, 158 patients of stage Ⅲ tuberculous empyema underwent uniportal VATS decortication with partial rib resection and customized periosteal stripper in Department of Thoracic Surgery, Shanghai Pulmonary Hospital. There were 127 males and 31 females, aged (M(IQR)) 32(28) years (range:14 to 78 years). Follow-up was performed in the outpatient clinic or via social communication applications, at monthly thereafter. If there was no air leak and chest tube drainage was less than 50 ml/day, a chest CT was performed. If the lung was fully re-expanded, chest tubes were removed. All patients received a follow-up chest CT 3 to 6 months following their initial operations which was compared to their preoperative imaging. Results: There was one conversion to open thoracotomy. The operative time was 2.75 (2.50) hours (range: 1.5 to 7.0 hours), and median blood loss was 100 (500) ml (range: 50 to 2 000 ml). There were no perioperative mortalities. There were no major complications except 1 case of redo-VATS for hemostasis due to excessive drainage and 1 case of incision infection, The incidence of prolonged air leaks (>5 days) was 80.3%(126/157). The postoperative hospital stay was 5.00 (2.25) days (range: 2 to 15 days). All patients were discharged with 2 chest tubes, and the median duration drainage was 21.00 (22.50) days (range: 3 to 77 days). Follow-up was completed in all patients over a duration of 20 (14) months (range: 12 to 44 months). At follow-up, 149 patients(94.9%) recovered to grade Ⅰ level, 7 patients to grade Ⅱ level, and 1 patient to grade Ⅲ level. Conclusion: Uniportal VATS decortication involving partial rib resection and a customized periosteal stripper is safe and effective for patients with stage Ⅲ tuberculous empyema. 目的: 探讨利用单孔胸腔镜技术对Ⅲ期结核性脓胸患者进行全纤维板剥脱术的可行性和技术要点。 方法: 回顾性分析2017年8月至2020年7月158例在上海市肺科医院胸外科接受单孔胸腔镜全纤维板剥脱治疗的Ⅲ期结核性脓胸患者的资料。男性127例,女性31例,年龄[M(IQR)]为32(28)岁(范围:14~78岁)。所有患者于全身麻醉下节段切除特定5 cm长肋骨,借助切口保护套暴露切口,获得操作空间,进而借助特殊器械进行全纤维板剥脱术。在无漏气、引流液清亮<50 ml/d后复查CT,肺较前复张后拔除胸腔引流管,继续抗结核治疗,术后3~6个月进行最终手术效果评估,后续门诊及电话随访至患者停药。 结果: 早期1例患者因纤维板过厚无法有效牵拉进而中转开胸,其他患者均按原计划完成手术。手术时间2.75(2.50)h(范围:1.5~7.0 h),术中出血量100(500)ml(范围:50~2 000 ml),术后住院时间5.00(2.25)d(范围:2~15 d),术后胸腔引流时间21.00(22.50)d(范围:3~77 d)。术后1例患者因胸腔引流量多进行开胸止血,1例发生切口感染,余无重大并发症。随访时间为20(14)个月(范围:12~44个月),所有患者无复发,149例达到Ⅰ级恢复,7例Ⅱ级恢复,1例Ⅲ级恢复。 结论: 借助特殊器械,单孔胸腔镜在Ⅲ期结核脓胸患者上进行全纤维板剥脱术是安全可行的,结合术后规范的抗结核治疗,远期恢复效果良好。.

来源:Zhonghua Wai Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhou YM, Hong Q, Yin GD, et al. [Uniportal thoracoscopic decortication for stage Ⅲ tuberculous empyema of 158 cases]. Zhonghua Wai Ke Za Zhi. 2022. PMID: 34954953. doi:10.3760/cma.j.cn112139-202100829-00398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。